Literature DB >> 24268809

Selective organ specific inflammation in offspring harbouring microchimerism from strongly alloreactive mothers.

Lucie Leveque1, Samantha Hodgson2, Stephen Peyton3, Motoko Koyama4, Kelli P A MacDonald4, Kiarash Khosrotehrani2.   

Abstract

The origins of autoimmunity are not yet understood despite significant advances in immunology. The trafficking of maternal cells to the offspring represents the very first immunological event in foetal life and is reinforced during lactation. The persistence of maternal cells in offspring's tissues and circulation has been associated with several autoimmune disorders. However a direct causal effect has never been demonstrated. Maternal T cells specifically targeting foetal insulin producing cells have been shown to generate islet inflammation without directly participating in this process. Our objective was to evaluate if alloreactive maternal cells could directly trigger a graft-versus host like reaction or indirectly influence the development of the offspring's regulatory T cells favouring autoimmunity. We adopted a breeding strategy comparing genetically identical offspring from either strongly alloreactive transgenic mothers compared to immunodeficient mothers. We detected maternal alloreactive T cells in the offspring and early signs of inflammation in small intestine of 6 weeks old offspring. Interestingly, CD4(+) Foxp3(+) regulatory T cell frequency was diminished in mesenteric lymph nodes from eight months old offspring born of alloreactive mothers compared to offspring of immunodeficient mothers. Our study favours a hypothesis where highly alloreactive maternal cell microchimerism indirectly predisposes offspring to autoimmunity. Crown
Copyright © 2013. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autoimmunity; Maternal microchimerism; Pregnancy; Regulatory T cells; Self-antigens

Mesh:

Substances:

Year:  2013        PMID: 24268809     DOI: 10.1016/j.jaut.2013.10.005

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  7 in total

Review 1.  Immunological implications of pregnancy-induced microchimerism.

Authors:  Jeremy M Kinder; Ina A Stelzer; Petra C Arck; Sing Sing Way
Journal:  Nat Rev Immunol       Date:  2017-05-08       Impact factor: 53.106

2.  Feto-maternal allo-immunity, regulatory T cells and predisposition to auto-immunity. Does it all start in utero?

Authors:  Lucie Leveque; Kiarash Khosrotehrani
Journal:  Chimerism       Date:  2014

3.  New insights in understanding biliary atresia from the perspectives on maternal microchimerism.

Authors:  Toshihiro Muraji; Ryuta Masuya; Toshio Harumatsu; Takafumi Kawano; Mitsuru Muto; Satoshi Ieiri
Journal:  Front Pediatr       Date:  2022-09-23       Impact factor: 3.569

4.  Vertically transferred maternal immune cells promote neonatal immunity against early life infections.

Authors:  Ina Annelies Stelzer; Christopher Urbschat; Steven Schepanski; Kristin Thiele; Ioanna Triviai; Agnes Wieczorek; Malik Alawi; Denise Ohnezeit; Julian Kottlau; Jiabin Huang; Nicole Fischer; Hans-Willi Mittrücker; Maria Emilia Solano; Boris Fehse; Anke Diemert; Felix R Stahl; Petra Clara Arck
Journal:  Nat Commun       Date:  2021-08-04       Impact factor: 14.919

5.  Chimeric cells of maternal origin do not appear to be pathogenic in the juvenile idiopathic inflammatory myopathies or muscular dystrophy.

Authors:  Carol M Artlett; Sihem Sassi-Gaha; Ronald C Ramos; Frederick W Miller; Lisa G Rider
Journal:  Arthritis Res Ther       Date:  2015-09-04       Impact factor: 5.156

6.  Advancing the detection of maternal haematopoietic microchimeric cells in fetal immune organs in mice by flow cytometry.

Authors:  Maria Emilia Solano; Kristin Thiele; Ina Annelies Stelzer; Hans-Willi Mittrücker; Petra Clara Arck
Journal:  Chimerism       Date:  2014-10-30

7.  Whole embryonic detection of maternal microchimeric cells highlights significant differences in their numbers among individuals.

Authors:  Kana Fujimoto; Akira Nakajima; Shohei Hori; Naoki Irie
Journal:  PLoS One       Date:  2021-12-23       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.